Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Enova International acquires payments platform Pangea Universal Enova International, a financial technology company, has acquired Pangea Universal, a payments platform based in Chicago that provides… byPallavi MadhirajuMarch 21, 2021
